+

WO1998008083A1 - Procede et appareil de detection de structures moleculaires predeterminees dans un echantillon - Google Patents

Procede et appareil de detection de structures moleculaires predeterminees dans un echantillon Download PDF

Info

Publication number
WO1998008083A1
WO1998008083A1 PCT/US1997/014372 US9714372W WO9808083A1 WO 1998008083 A1 WO1998008083 A1 WO 1998008083A1 US 9714372 W US9714372 W US 9714372W WO 9808083 A1 WO9808083 A1 WO 9808083A1
Authority
WO
WIPO (PCT)
Prior art keywords
pattern
sample
molecular structure
binding sites
predetermined molecular
Prior art date
Application number
PCT/US1997/014372
Other languages
English (en)
Inventor
William L. Reber
Donald E. Ackley
Cary D. Perttunen
Original Assignee
Motorola Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Motorola Inc. filed Critical Motorola Inc.
Priority to AU43276/97A priority Critical patent/AU4327697A/en
Publication of WO1998008083A1 publication Critical patent/WO1998008083A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Definitions

  • the present invention relates to methods and system for molecular detection.
  • a molecular detection chip typically includes a substrate on which an array of binding sites is arranged. Each binding site, or hybridization site, has a respective molecular receptor which binds or hybridizes with a molecule having a predetermined structure.
  • a sample solution is applied to the molecular detection chip, and molecules in the sample bind or hybridize at one or more of the binding sites. The particular binding sites at which hybridization occurs are detected, and one or more molecular structures within the sample are subsequently deduced.
  • molecular detection chips for gene sequencing These chips, often referred to as DNA chips, utilize an array of selective binding sites each having respective single-stranded DNA probes.
  • a sample of single- stranded DNA fragments referred to as target DNA, is applied to the DNA chip. The DNA fragments attach to one or more of the DNA probes by a hybridization process. By detecting which DNA probes have a DNA fragment hybridized thereto, a sequence of nucleotide bases within the DNA fragment can be determined.
  • molecular detection chips One use of molecular detection chips is to perform medical diagnostics.
  • a genomic sample from an individual is screened to determine if the individual has a genetically-inherited disease or a genetic predisposition to disease.
  • medical diagnostics migrate to miniature devices capable of performing higher numbers of tests with greater sensitivity, there is a corresponding increase in the amount of information being generated, and in the demand for greater processing power to obtain test results .
  • FIG. 1 is a flow chart of an embodiment of a method of detecting a predetermined molecular structure in a sample
  • FIG. 2 is a flow chart of an embodiment of a method of generating the reference pattern
  • FIG. 3 is a flow chart of another embodiment of a method of generating the reference pattern;
  • FIG. 4 illustrates an array of binding sites on a molecular detection device used in the specific embodiment;
  • FIG. 5 illustrates a reference pattern for detecting an a-c-g nucleotide sequence in a sample
  • FIG. 6 illustrates a reference pattern for detecting an a-c-t nucleotide sequence in a sample
  • FIG. 7 is an example of a pattern generated by a sample having an unknown molecular structure
  • FIG. 8 is a flow chart of additional steps which can be utilized to detect the predetermined molecular structure
  • FIG. 9 is a block diagram of an apparatus for detecting a predetermined molecular structure in a sample
  • FIG. 10 is a flow chart of an embodiment of a method of gene discovery in accordance with the present invention.
  • Embodiments of the present invention advantageously provide improved information processing approaches to detecting predetermined molecular structures using a miniaturized device having an array of biological sensors.
  • a diagnostic device in accordance with the present invention is designed to perform one or more specific diagnostic tests.
  • FIG. 1 is a flow chart of an embodiment of a method of detecting a predetermined molecular structure in a sample.
  • the method can be utilized for detection of a variety of molecular structures in a variety of different types of samples. Examples of the different types of samples include, but are not limited to, medical samples, environmental samples, agricultural samples, and other samples applicable to diagnostics.
  • the predetermined molecular structure can be any indication of a structure of molecules contained in the sample.
  • the predetermined molecular structure can be indicative of a presence of a pathogen in an environmental sample such as water.
  • the predetermined molecular structure can provide an indication of crop resistance, for example.
  • a predetermined molecular structure can be indicative of a disease gene .
  • a predetermined nucleotide base sequence in a sample from a living organism or a plant.
  • the sample can include a DNA sample or an RNA sample, for example.
  • the predetermined nucleotide base sequence can be associated with a genetically-inherited disease and/or a genetic predisposition to disease of the individual, for example. Detection of these types of molecular structures allow medical personnel to formulate an appropriate treatment strategy for the individual .
  • a step of providing a molecular detection device is performed.
  • Various types of molecular detection devices can be utilized. Such molecular detection devices include, but are not limited to, molecular detection chips, DNA chips, biosensor arrays, genosensor arrays, and the like.
  • the molecular detection device typically includes a plurality binding sites or hybridization sites which are arranged as an array on a substrate. Each binding site has a respective molecular receptor which specifically binds or hybridizes with a molecule having a predetermined structure.
  • Each molecular receptor typically includes a biological or synthetic molecule having a specific affinity to the molecule to be detected.
  • a molecular receptor having a chain of at least one nucleotide to hybridize with a molecule having a complementary chain of at least one nucleotide.
  • the molecular receptor can include a DNA probe for detecting a corresponding, complementary DNA sequence in the sample.
  • the scope of the invention is not limited to sensing the hybridization of DNA molecules.
  • embodiments of the present invention can be utilized to detect RNA hybridization and antibody- antigen binding events.
  • the molecular detection device can include an array of detection sites, such as in the context of an oligonucleotide ligation assay (OLA) .
  • OLA oligonucleotide ligation assay
  • pairs of oligonucleotides are utilized to amplify a selected oligonucleotide sequence.
  • a corresponding detection site is screened for full-length ligated oligonucleotides using any of the sensing approaches described herein.
  • an optional step of tagging molecules within the sample is performed.
  • Each molecule is tagged with a member which can be sensed by the molecular detection device.
  • Such members are commonly referred to in the art as tags, markers, and labels. Examples of such members include, but are not limited to, radioactive members, optical members (such as fluorescent members, luminescent members, and light-scattering members) , charged members, and magnetic members.
  • a step of applying the sample to the molecular detection device is performed. Thereafter, the sample is allowed to hybridize at one or more of the binding sites, as indicated by block 16.
  • the sample specifically binds to at least one of the binding sites, and non-specifically binds to at least another one of the binding sites.
  • specific binding it is meant that an intended target molecule is bound to a molecular receptor.
  • nonspecific binding it is meant that an unintended target molecule is bound to a molecular receptor.
  • the molecular receptor includes a chain of at least one nucleotide
  • specific binding occurs with a molecule having a complementary chain of the at least one nucleotide.
  • Non-specific binding with such a molecular receptor occurs with a molecule having at least one mismatching base.
  • a local concentration of molecules in the sample can be increased at predetermined sites using electric field enhancements.
  • each site has an electrode associated therewith for selectively generating an electric field thereby.
  • the electric field is generated by applying an electric potential between an electrode at the site and a counter electrode.
  • the polarity of the electric potential is selected to generate an electric field having a polarity opposite to the charge of the molecules.
  • an optional step of removing unwanted molecules from the binding sites can be performed, as indicated by block 18.
  • the step of removing unwanted molecules can be performed by generating an electric field having the same polarity as the charge of the unwanted molecules.
  • the electric field acts to repel unwanted molecules from the binding sites.
  • a thermally-assisted approach can be utilized to remove unwanted molecules.
  • the temperature at the binding sites is raised, in dependence upon a melting temperature, to dissociate partially-bound molecules from the molecular receptors.
  • the unwanted molecules to be dehybridized can include unbound molecules and partially-bound (i.e. non-specifically bound) molecules.
  • the step of removing unwanted molecules does not remove all unwanted molecules from the binding sites. This step is beneficial, however, in improving the accuracy of detection as outlined in subsequent steps.
  • the method includes a step of sensing a pattern in which the sample binds to an array of binding sites in a molecular detection device.
  • the pattern can be sensed using a variety of approaches, including but not limited to, optical approaches, radioactive-sensing approaches, electronic approaches, and magnetic approaches. The specific approach utilized depends upon the type of tagging member attached to the molecules in the sample.
  • the step of sensing the pattern includes sensing an intensity or a magnitude of binding at each of a plurality of the array of binding sites.
  • Each intensity can be indicative of a number of molecules bound at a respective binding site, a binding strength at a respective binding site, and/or a melting temperature for the binding at a respective binding site.
  • the step of sensing the pattern includes capturing at least one image of the pattern.
  • the image is formed by luminescent light, fluorescent light or a scattering of light associated with a hybridization event.
  • the image can be captured using a CCD camera, a confocal microscope, or other like imaging device.
  • the image indicates an intensity or magnitude of binding at each of the binding sites by a measure of illumination.
  • the measure of illumination at a binding site can be based on a gray scale or the like at the location of the binding site on the image.
  • the intensity of binding at a binding site is based on an average illumination (e.g. an average gray scale) at the binding site.
  • the method includes a step of comparing the pattern to a reference pattern to detect the predetermined molecular structure in the sample.
  • the step of comparing includes determining a correlation between the pattern and the reference pattern.
  • the predetermined molecular structure can be detected when a measure of the correlation is within a predetermined range.
  • the step of comparing includes determining a difference between the pattern and the reference pattern.
  • the predetermined molecular structure can be detected when a measure of the difference is within a predetermined range.
  • the step of comparing includes a step of comparing at least one image of the pattern to an image of the reference pattern.
  • the method optionally comprises a step of determining a confidence level of detecting the predetermined molecular structure in the sample.
  • the confidence level indicates a degree of significance of the result obtained in the step of comparing in block 22.
  • the steps indicated by blocks 22 and 24 can be repeated for a plurality of different reference patterns.
  • a genomic sample can be screened to determine if it contains any of a plurality of predetermined base sequences .
  • FIG. 2 is a flow chart of an embodiment of a method of generating the reference pattern. Typically, the reference pattern is generated prior to performing the steps indicated in FIG. 1.
  • the method includes a step of providing a reference device having a like array of binding sites as the molecular detection device used for detection. If desired, the same molecular detection device can be utilized for generating the reference pattern and for subsequent detection of an unknown molecular structure in a sample. Typically, however, another like device is utilized.
  • an optional step of tagging molecules in a reference sample is performed.
  • the reference sample is selected to contain the predetermined molecular structure which is to be detected.
  • a step of applying the reference sample to the reference device is performed.
  • the reference sample is allowed to hybridize at one or more of the binding sites.
  • a step of removing unwanted molecules from the binding sites is performed, as indicated by block 38.
  • a step of sensing a pattern in which the reference sample binds to the like array of binding sites is performed.
  • This pattern is utilized as the reference pattern for subsequent comparison.
  • the reference pattern is sensed using the same approach as utilized for subsequent detection steps. It is further preferred that an intensity of binding at each of the binding sites in the like array be included in the reference pattern.
  • an optional step of modifying a temperature at the binding sites is performed.
  • the temperature is raised to dissociate weakly bound molecules from the binding sites.
  • the step of sensing the pattern, indicated by block 40 is repeated.
  • the temperature can be repeatedly raised to generate a plurality of temperature-dependent reference patterns.
  • the reference device can be washed, and the steps indicated by blocks 32, 34, 36, 38, 40, and 42 can be repeated for another reference sample containing the same predetermined molecular structure.
  • the steps indicated by blocks 30, 32, 34, 36, 38, 40, and 42 can be repeated to apply the same predetermined molecular structure to a number of like reference devices. Either approach may be utilized to provide a plurality of reference patterns for the same predetermined molecular structure.
  • Sensed patterns formed by a sample having an unknown molecular structure can be compared to each of the above-described plurality of reference patterns, or a statistical model thereof, to detect the predetermined molecular structure in the sample.
  • FIG. 3 is a flow chart of another embodiment of a method of generating the reference pattern.
  • the method includes a step of determining an architecture of the array of binding sites of the molecular detection device. This step can include determining a layout of the binding sites, and determining the type of molecular receptor at each of the binding sites.
  • the method includes a step of predicting a reference pattern in which the predetermined molecular structure binds to the array of binding sites.
  • the reference pattern is predicted based upon the predetermined molecular structure and the architecture of the molecular detection device.
  • the reference pattern includes a predicted intensity of binding at each of the binding sites. Regardless of the approach taken, the reference pattern acts as a novelty filter which is predictive of a successful or a desirable test result.
  • FIGS. 4 to 7 illustrate the detection of a predetermined molecular structure in accordance with a specific embodiment of the present invention. In this simplified example, a predetermined sequence of nucleotide bases is detected in a genomic sample, such as a DNA sample.
  • FIG. 4 illustrates an array of binding sites 60 on a molecular detection device used in the specific embodiment.
  • the array of binding sites 60 contains all possible single-stranded DNA probes having a length of three bases. It is noted that molecular detection devices used in practice typically have more binding sites. For example, 256x256 arrays containing all possible 8-mer DNA probes are commonly utilized.
  • the respective base sequence at each binding site is indicated using standard nucleotide abbreviations ("a” representing adenine, "c” representing cytosine, "g” representing guanine, and "t” representing thymine) .
  • each DNA probe is utilized to detect molecules having a complementary sequence of nucleotide bases.
  • FIG. 5 illustrates a reference pattern for detecting an a-c-g nucleotide sequence in a sample.
  • the reference pattern indicates an intensity of binding at each of the binding sites by an intensity of illumination.
  • darker sites are indicative of lower binding intensities, while brighter sites are indicative of higher binding intensities.
  • a binding site 62 having a t-g-c sequence, which is complementary to the a-c-g sequence, has the greatest intensity of binding.
  • Binding sites with no matching complementary bases, such as those indicated by reference numeral 68 have a low intensity of binding.
  • FIG. 6 illustrates a reference pattern for detecting an a-c-t nucleotide sequence in a sample.
  • the reference patterns in FIGS. 5 and 6 can be sensed using a reference sample, or can be predicted based on the number of mismatching bases at each binding site.
  • FIG. 7 is an example of a pattern generated by a sample having an unknown molecular structure.
  • the pattern is generated by applying a sample of tagged single-stranded DNA molecules to the molecular detection device, allowing the molecules to hybridize to the binding sites, and optionally removing unwanted molecules.
  • the resulting pattern shows a high intensity of binding at a t-g-a site 70.
  • the sample includes an a-c-t nucleotide sequence (i.e. the complement of t-g-a).
  • the overall pattern is better correlated to the reference pattern for the a-c-g nucleotide sequence (in FIG. 5) than to the reference pattern for a-c-t (in FIG. 6) .
  • the pattern is significantly correlated to the reference pattern in FIG. 5.
  • the method of the present invention would conclude that the sample includes the a-c-g nucleotide sequence.
  • the pattern in FIG. 7 can be compared to the reference patterns in FIG. 5 and FIG. 6 using any of a variety of correlation measures and/or difference measures.
  • a difference measure can be formulated using intensity differences (between the pattern and the reference pattern) for each of the binding sites.
  • the difference measure can be a sum of absolute differences, a maximum difference, a root-mean square difference, or any other suitable function of the intensity differences.
  • a correlation measure can be formulated using a coefficient of correlation between the pattern intensities and the reference intensities. In general, any linear or nonlinear function of the pattern intensities and the reference intensities can be utilized to compare the pattern to the reference pattern.
  • FIG. 8 is a flow chart of additional steps which can be utilized to detect the predetermined molecular structure. The steps illustrated here can be performed after performing the steps indicated by blocks 10, 12, 14, 16 and 18 in FIG. 1.
  • a step of modifying a temperature at the binding sites is performed.
  • the temperature is raised to dissociate weakly bound molecules from the binding sites .
  • the temperature can be independently modified at selected binding sites, or can be modified for all of the binding sites.
  • a step of sensing a pattern is performed.
  • a plurality of temperature-dependent patterns is generated.
  • a step of comparing at least one of the plurality of temperature-dependent patterns to a corresponding at least one of a plurality of temperature-dependent reference patterns is performed.
  • each of the temperature-dependent patterns can be compared to a corresponding one of the temperature-dependent reference patterns.
  • only selected ones of the temperature-dependent patterns can be compared to corresponding reference patterns.
  • a correlation measure and/or a difference measure is computed based on this comparison.
  • a predetermined molecular structure is detected when the measure is within a predetermined range.
  • the temperature-dependent pattern having a greatest variability of intensity is selected for comparison.
  • the variability of intensity is greatest at a temperature which dissociates many non-specifically-bound molecules, but does not significantly dissociate specifically- bound molecules.
  • This pattern can be compared with a corresponding reference pattern to detect a predetermined molecular structure. It is noted that a variety of different measures of variability can be utilized, including but not limited to, sample variance and sample standard deviation.
  • FIG. 9 is a block diagram of an apparatus for detecting a predetermined molecular structure in a sample.
  • the apparatus includes an array of binding sites 90 each having a respective molecular receptor.
  • a sensor 92 provides means for sensing the pattern in which the sample binds to the array of binding sites 90.
  • Various types of sensors can be utilized, as described earlier.
  • a memory 94 contains a library of at least one reference pattern.
  • the memory 94 contains a library of a plurality of reference patterns so that the apparatus can be utilized for detecting any of a plurality of predetermined molecular structures in the sample.
  • a processor 96 is operatively associated with the sensor 92 and the memory 94.
  • the processor 96 provides means for comparing the pattern sensed by the sensor 92 to the reference patterns stored in the memory. Based on the comparison (s) , the processor 96 outputs an indication of which predetermined molecular structure is detected, and a confidence level therefor.
  • the array of binding sites are operatively associated with the sensor 92 and the memory 94.
  • the processor 96 provides means for comparing the pattern sensed by the sensor 92 to the reference patterns stored in the memory. Based on the comparison (s) , the processor 96 outputs an indication of which predetermined molecular structure is detected, and a confidence level therefor.
  • the array of binding sites is operatively associated with the sensor 92 and the memory 94.
  • the processor 96 provides means for comparing the pattern sensed by the sensor 92 to the reference patterns stored in the memory. Based on the comparison (s) , the processor 96 outputs an indication of which predetermined molecular structure is detected, and
  • the above-described apparatus can be utilized to perform the steps described for FIGS. 1 and 8.
  • one or more heating elements 98 can be incorporated in the device.
  • the heating elements 98 are preferably controlled by the processor 96 to form a plurality of temperature-dependent patterns.
  • FIG. 10 is a flow chart of an embodiment of a method of gene discovery in accordance with the present invention.
  • the method includes a step of sensing a pattern of detection for a sample applied to a molecular detection device having a plurality of detection sites.
  • the sample is taken from a first species having unknown genes to be discovered. Any of the various approaches described herein can be utilized for sensing the pattern.
  • the method includes a step of determining an architecture of the plurality of detection sites of the molecular detection device.
  • a step of reading a nucleotide sequence from a database is performed, as indicated by block 104.
  • any nucleotide sequence can be read.
  • the nucleotide sequence can include a gene from a fruit fly, -while the sample in which gene discovery is to be performed is from a human.
  • the method includes a step of predicting a reference pattern which would be detected if the nucleotide sequence were applied to the molecular detection device. As indicated by block 108, a step of comparing the pattern to the reference pattern is performed to determine whether the nucleotide sequence is within the sample.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Il est possible de détecter le motif d'une structure moléculaire prédéterminée dans un échantillon par détection d'un motif dans lequel l'échantillon se fixe à un ensemble de sites de fixation, au moyen d'un dispositif de détection moléculaire (20), puis par comparaison dudit motif à un motif de référence pour détecter la structure moléculaire prédéterminée dans l'échantillon (22). Dans une variante, le motif de référence est obtenu par détection d'un échantillon dans lequel un échantillon de référence contenant les structures moléculaires prédéterminées se fixe à un ensemble analogue de sites de fixation. Dans une autre variante, l'échantillon de référence est produit par prédiction d'un motif dans lequel la structure moléculaire prédéterminée se fixe à l'ensemble de sites de fixation.
PCT/US1997/014372 1996-08-20 1997-08-13 Procede et appareil de detection de structures moleculaires predeterminees dans un echantillon WO1998008083A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU43276/97A AU4327697A (en) 1996-08-20 1997-08-13 Method and apparatus for detecting predetermined molecular structures in a sample

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70018296A 1996-08-20 1996-08-20
US08/700,182 1996-08-20

Publications (1)

Publication Number Publication Date
WO1998008083A1 true WO1998008083A1 (fr) 1998-02-26

Family

ID=24812499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/014372 WO1998008083A1 (fr) 1996-08-20 1997-08-13 Procede et appareil de detection de structures moleculaires predeterminees dans un echantillon

Country Status (2)

Country Link
AU (1) AU4327697A (fr)
WO (1) WO1998008083A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000039580A1 (fr) * 1998-12-23 2000-07-06 University Of Sydney Essai pour la detection d'un partenaire de liaison
WO2003072817A3 (fr) * 2002-02-28 2003-12-31 Febit Ag Augmentation de la sensibilite et de la specificite de tests d'hybridation avec des puces a acide nucleique
US6720138B2 (en) 1997-04-30 2004-04-13 Diagenic As Method of preparing a standard diagnostic gene transcript pattern
DE10324912A1 (de) * 2003-05-30 2005-01-05 Siemens Ag Verfahren zur Detektion von DNA-Punktmutationen (SNP-Analyse) sowie zugehörige Anordnung
EP1947116A2 (fr) 2003-02-10 2008-07-23 TO-BBB Holding B.V. Acides nucléiques exprimés par action différentielle dans la barrière hématoencéphalique sous des conditions inflammatoires
WO2010087702A1 (fr) 2009-01-30 2010-08-05 Stichting Katholieke Universiteit Gène tet2 en tant que marqueur pour diagnostiquer un syndrome myélodysplasique (mds) ou une leucémie myéloïde aiguë (aml) et déterminer le pronostic chez un sujet
WO2011034421A1 (fr) 2009-09-16 2011-03-24 Stichting Het Nederlands Kanker Instituut Gènes cibles fra-1 utilisés comme cibles médicamenteuses pour le traitement du cancer
US8105773B2 (en) 2004-06-02 2012-01-31 Diagenic As Oligonucleotides for cancer diagnosis
WO2014007623A1 (fr) 2012-07-03 2014-01-09 Interna Technologies B.V. Portefeuille de diagnostic et ses utilisations

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532128A (en) * 1991-11-19 1996-07-02 Houston Advanced Research Center Multi-site detection apparatus
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532128A (en) * 1991-11-19 1996-07-02 Houston Advanced Research Center Multi-site detection apparatus
US5605662A (en) * 1993-11-01 1997-02-25 Nanogen, Inc. Active programmable electronic devices for molecular biological analysis and diagnostics
US5571639A (en) * 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PROC. NATL. ACAD. SCI. U.S.A., July 1995, Vol. 92, STIMPSON D.I., "Real-Time Detection of DNA Hybridization and Melting on Oligonucleotide Arrays by Using Optical Wave Guides", pages 6379-6383. *
PROC. NATL. ACAD. SCI. U.S.A., May 1994, Vol. 91, PEASE A.C., "Light-Generated Oligonucleotide Arrays for Rapid DNA Sequence Analysis", pages 5022-5026. *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720138B2 (en) 1997-04-30 2004-04-13 Diagenic As Method of preparing a standard diagnostic gene transcript pattern
WO2000039580A1 (fr) * 1998-12-23 2000-07-06 University Of Sydney Essai pour la detection d'un partenaire de liaison
US7560226B2 (en) 1998-12-23 2009-07-14 Medsaic Pty Limited Assay to detect a binding partner
WO2003072817A3 (fr) * 2002-02-28 2003-12-31 Febit Ag Augmentation de la sensibilite et de la specificite de tests d'hybridation avec des puces a acide nucleique
EP1947116A2 (fr) 2003-02-10 2008-07-23 TO-BBB Holding B.V. Acides nucléiques exprimés par action différentielle dans la barrière hématoencéphalique sous des conditions inflammatoires
DE10324912A1 (de) * 2003-05-30 2005-01-05 Siemens Ag Verfahren zur Detektion von DNA-Punktmutationen (SNP-Analyse) sowie zugehörige Anordnung
US7488578B2 (en) 2003-05-30 2009-02-10 Siemens Aktiengesellschaft Method for detecting DNA point mutations (single nucleotide polymorphism (SNP) analysis) and associated arrangement
US8105773B2 (en) 2004-06-02 2012-01-31 Diagenic As Oligonucleotides for cancer diagnosis
WO2010087702A1 (fr) 2009-01-30 2010-08-05 Stichting Katholieke Universiteit Gène tet2 en tant que marqueur pour diagnostiquer un syndrome myélodysplasique (mds) ou une leucémie myéloïde aiguë (aml) et déterminer le pronostic chez un sujet
WO2011034421A1 (fr) 2009-09-16 2011-03-24 Stichting Het Nederlands Kanker Instituut Gènes cibles fra-1 utilisés comme cibles médicamenteuses pour le traitement du cancer
WO2014007623A1 (fr) 2012-07-03 2014-01-09 Interna Technologies B.V. Portefeuille de diagnostic et ses utilisations

Also Published As

Publication number Publication date
AU4327697A (en) 1998-03-06

Similar Documents

Publication Publication Date Title
US20230204538A1 (en) Methods and apparatus for measuring analytes using large scale molecular electronics sensor arrays
US6171793B1 (en) Method for scanning gene probe array to produce data having dynamic range that exceeds that of scanner
US6926865B2 (en) Method and apparatus for detecting DNA hybridization
JP4029921B2 (ja) 光ファイバーバイオセンサ用高密度アレイの製造法と読出法
US8241893B2 (en) Method and device for separating molecular targets in a complex mixture
US20100270174A1 (en) Biosensor cell and biosensor array
US20210350163A1 (en) Equalization-Based Image Processing and Spatial Crosstalk Attenuator
Lennon High-throughput gene expression analysis for drug discovery
Walt Imaging optical sensor arrays
US20080215252A1 (en) Method of Determining Base Sequence of Nucleic Acid and Apparatus Therefor
WO1998008083A1 (fr) Procede et appareil de detection de structures moleculaires predeterminees dans un echantillon
Belosludtsev et al. Organism identification using a genome sequence-independent universal microarray probe set
JP2000228999A (ja) 個体の集団の多重遺伝子型
US20080044821A1 (en) Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes
US20050266455A1 (en) Method and microelectronic device for multi-site molecule detection
JP3944576B2 (ja) マイクロアレイを用いたアプタマーの取得方法
US20100056388A1 (en) Nucleic acid array having fixed nucleic acid anti-probes and complementary free nucleic acid probes
JP2006506605A (ja) ｍＲＮＡの絶対量を測定する方法及びシステム
US6218116B1 (en) Method and device for treatment by complexing of a liquid medium
JP2003310257A (ja) 肺炎クラミジアのｄｎａマイクロアレイ、肺炎クラミジア感染の有無を検査する方法および薬物のスクリーニング方法
US20050095595A1 (en) Methods and systems for improving of polymer analysis
Leslie et al. Differential display: a practical approach
US20080003589A1 (en) Method of measuring repeat number of unit base
US20050226535A1 (en) Method and system for rectilinearizing an image of a microarray having a non-rectilinear feature arrangement
EP3677690A1 (fr) Méthode et dispositif pour l'analyse d'acides nucléiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 98510835

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载